JPS4961170A - - Google Patents

Info

Publication number
JPS4961170A
JPS4961170A JP48068634A JP6863473A JPS4961170A JP S4961170 A JPS4961170 A JP S4961170A JP 48068634 A JP48068634 A JP 48068634A JP 6863473 A JP6863473 A JP 6863473A JP S4961170 A JPS4961170 A JP S4961170A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP48068634A
Other languages
Japanese (ja)
Other versions
JPS5711908B2 (enExample
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4961170A publication Critical patent/JPS4961170A/ja
Publication of JPS5711908B2 publication Critical patent/JPS5711908B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
JP6863473A 1972-06-19 1973-06-18 Expired JPS5711908B2 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2229695A DE2229695A1 (de) 1972-06-19 1972-06-19 2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
JPS4961170A true JPS4961170A (enExample) 1974-06-13
JPS5711908B2 JPS5711908B2 (enExample) 1982-03-08

Family

ID=5848060

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6863473A Expired JPS5711908B2 (enExample) 1972-06-19 1973-06-18

Country Status (13)

Country Link
US (1) US3931194A (enExample)
JP (1) JPS5711908B2 (enExample)
AT (6) AT329200B (enExample)
BE (1) BE801079A (enExample)
CH (9) CH583228A5 (enExample)
DE (1) DE2229695A1 (enExample)
DK (1) DK136904C (enExample)
ES (8) ES416037A1 (enExample)
FR (1) FR2189056B1 (enExample)
GB (1) GB1433817A (enExample)
NL (1) NL7308483A (enExample)
NO (1) NO137694C (enExample)
SE (1) SE405121B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011503150A (ja) * 2007-11-16 2011-01-27 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ベンゾモルファン及び関連骨格のアリール−及びヘテロアリールカルボニル誘導体、かかる化合物を含有する医薬及びこれらの使用

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2437610A1 (de) * 1974-08-05 1976-02-26 Boehringer Sohn Ingelheim Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung
GB1575009A (en) * 1976-06-21 1980-09-17 Acf Chemiefarma Nv 6,7-benzomorphan derivatives
JPS63177704A (ja) * 1987-01-16 1988-07-21 松山株式会社 農作業機連結装置
ES2395081T3 (es) 2007-07-26 2013-02-08 Vitae Pharmaceuticals, Inc. Síntesis de inhibidores de la 11beta-hidroxiesteroide deshidrogenasa de tipo 1
EP2229368A1 (en) 2007-12-11 2010-09-22 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
JP5490020B2 (ja) 2008-01-24 2014-05-14 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状カルバゼート及びセミカルバジドインヒビター
US20110028445A1 (en) * 2008-02-12 2011-02-03 Boehringer Ingelheim International Gmbh Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
JP5730021B2 (ja) 2008-02-15 2015-06-03 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の阻害剤としてのシクロアルキルラクタム誘導体
CL2009001058A1 (es) 2008-05-01 2010-09-10 Vitae Pharmaceuticals Inc Compuestos derivados de oxazinas sustituidas, inhibidores de la 11b-hidroxiesteroide deshidrogenasa de tipo-1; composicion farmaceutica; y uso del compuesto para inhibir la actividad de 11b-hsd1, como en el tratamiento de la diabetes, dislipidemia, hipertension, obesidad, cancer, glaucoma, entre otras.
TW200946520A (en) 2008-05-01 2009-11-16 Vitae Pharmaceuticals Inc Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2723034A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2724214A1 (en) 2008-05-13 2009-11-19 Boehringer Ingelheim International Gmbh Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
EP2324018B1 (en) 2008-07-25 2013-09-04 Boehringer Ingelheim International GmbH Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
CA2729998A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
UA109255C2 (ru) 2009-04-30 2015-08-10 Берінгер Інгельхайм Інтернешнл Гмбх Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
EP2440537A1 (en) 2009-06-11 2012-04-18 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
UY33001A (es) * 2009-11-06 2011-05-31 Boehringer Ingelheim Int Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina
WO2011159760A1 (en) 2010-06-16 2011-12-22 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基－及雜環芳基羰基衍生物
US8735585B2 (en) 2011-08-17 2014-05-27 Boehringer Ingelheim International Gmbh Indenopyridine derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE582575A (enExample) * 1958-09-22
FR1281227A (fr) * 1958-09-22 1962-01-12 Smith Kline French Lab Perfectionnements apportés aux procédés pour la préparation de dérivés d'aralcoylbenzomorphane
CS166802B2 (enExample) * 1971-02-08 1976-03-29 Boehringer Sohn Ingelheim
SE392895B (sv) * 1971-08-24 1977-04-25 Sumitomo Chemical Co Forfarande for framstellning av bensomorfanderivat och deras salter

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011503150A (ja) * 2007-11-16 2011-01-27 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ベンゾモルファン及び関連骨格のアリール−及びヘテロアリールカルボニル誘導体、かかる化合物を含有する医薬及びこれらの使用
JP2015199770A (ja) * 2007-11-16 2015-11-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ベンゾモルファン及び関連骨格のアリール−及びヘテロアリールカルボニル誘導体、かかる化合物を含有する医薬及びこれらの使用

Also Published As

Publication number Publication date
ES431513A1 (es) 1976-11-01
CH583231A5 (enExample) 1976-12-31
AT328628B (de) 1976-03-25
AU5704673A (en) 1974-12-19
ES431511A1 (es) 1976-11-01
ES431512A1 (es) 1976-11-01
CH589648A5 (enExample) 1977-07-15
CH582698A5 (enExample) 1976-12-15
CH582697A5 (enExample) 1976-12-15
AT329200B (de) 1976-04-26
DE2229695A1 (de) 1974-01-31
BE801079A (fr) 1973-12-18
CH583228A5 (enExample) 1976-12-31
CH583229A5 (enExample) 1976-12-31
ATA490074A (de) 1975-06-15
CH583230A5 (enExample) 1976-12-31
AT328627B (de) 1976-03-25
DK136904C (da) 1978-06-26
AT329199B (de) 1976-04-26
GB1433817A (en) 1976-04-28
AT325218B (de) 1975-10-10
AT328629B (de) 1976-03-25
ES431514A1 (es) 1976-11-01
CH589649A5 (enExample) 1977-07-15
ATA489474A (de) 1975-06-15
US3931194A (en) 1976-01-06
SE405121B (sv) 1978-11-20
ES431510A1 (es) 1976-11-01
NO137694B (no) 1977-12-27
JPS5711908B2 (enExample) 1982-03-08
FR2189056B1 (enExample) 1976-10-22
ES416037A1 (es) 1976-02-16
FR2189056A1 (enExample) 1974-01-25
ES431515A1 (es) 1976-11-01
ATA489774A (de) 1975-06-15
ATA489874A (de) 1975-07-15
ATA489974A (de) 1975-07-15
ES431516A1 (es) 1976-11-16
DK136904B (da) 1977-12-12
NO137694C (no) 1978-04-05
CH583227A5 (enExample) 1976-12-31
NL7308483A (enExample) 1973-12-21

Similar Documents

Publication Publication Date Title
JPS5711908B2 (enExample)
CS161675B2 (enExample)
CS168681B2 (enExample)
CS172877B2 (enExample)
CS160327B1 (enExample)
CS159037B1 (enExample)
CS163472B1 (enExample)
CS159105B1 (enExample)
CS158496B1 (enExample)
CS163514B1 (enExample)
CS163016B1 (enExample)
CS162895B1 (enExample)
CS161625B1 (enExample)
CS160398B1 (enExample)
CS160333B1 (enExample)
CS160332B1 (enExample)
CS159940B1 (enExample)
CS158519B1 (enExample)
CS156312B1 (enExample)
CS158487B1 (enExample)
CS157391B1 (enExample)
CS156320B1 (enExample)
CS149971B1 (enExample)
CS150888B1 (enExample)
CS151832B1 (enExample)